{"id": "1334884068044001286", "creation": 1607096137.0, "user_id": "18026170", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "In Ph1 #ClinicalTrials, #CloverBiopharma\u2019s #COVID19 S-trimer vaccine offers 100% #seroconversion in adults; 88-100% in the #elderly\n\n#Vaccine, stable at 2-8\u00b0 C, #adjuvanted w/ @GSK\u2019s #pandemic system or @DynavaxCorp\u2019s CpG 1018 plus alum\n\nhttps://t.co/fkoZ61ZH5A\n#SARSCoV2 https://t.co/SjZvWSAwxu", "first_save": 1634559108.199414, "hashtags": ["#CLINICALTRIALS", "#CLOVERBIOPHARMA", "#COVID19", "#SEROCONVERSION", "#ELDERLY", "#VACCINE", "#ADJUVANTED", "#PANDEMIC", "#SARSCOV2"]}